Opioid Use Disorder Treatment Market Report 2023: R&D Consistency Drives Sector Growth

in pharmaceutical •  2 years ago 

FMI-New-4.png
The global Opioid Use Disorder Treatment Market size is expected to attain an impressive valuation of US$ 3.07 billion in 2023 and is projected to reach US$ 8.4 billion by 2033, expanding at a CAGR of 10.5% during the forecast period. Drug abuse treatment providers and manufacturers are primarily concerned with raising public and drug store owner knowledge of the serious consequences of drug misuse and the significance of abuse therapy. This expands their consumer base, which directly contributes to the market expansion of Opioid use disorder treatment. Raising awareness through television commercials, newspapers, information booklets, and other media is proving to be quite beneficial in slowing the opioid abuse issue to some level.

There are numerous organisations that collaborate with other groups to advance the industry. For example, in March 2016, GlaxoSmithKline partnered with 2morrow Inc., the producer of the SmartQuit app, to provide patches to smokers who had purchased the app plan. Similarly, in August 2013, the business agreed with Amneal Pharmaceuticals LLC to distribute its Buprenorphine HCl and Naloxone HCl Dihydrate Sublingual Tablets (CIII), a generic form of Suboxon, to addiction treatment facilities. Long-term, this will boost the market.

On the other hand, the recent addiction epidemic has prompted the need to invest in integrated research and development initiatives focused on addiction treatment and the recovery process. Despite the fact that the number of research activities pertaining to issues related to Opioid use disorder has increased at an impressive rate, stakeholders operating in the current treatment market landscape are progressively discovering new ways to apply these findings in real-world care delivery. This is projected to propel market expansion in the near future.

Competitive Landscape

The Opioid use disorder treatment Market is competitive and consists of several major players. Major players are creating novel delivery systems for the treatment of opioid use disorder. This is expected to propel Opioid use disorder treatment market. The major players in the market are: Trevena, Opiate Pharmaceutical, Aphios, Kyowa kirin, Gamida-Cell, Novartis, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals, MediciNova, Alkermes, Inc., BioDelivery Sciences International, Inc.

Browse More@ https://www.futuremarketinsights.com/reports/opioid-use-disorder-treatment-market

Key Segments Profiled in the Opioid Use Disorder Treatment Market Survey

By Drug Type:

Romiplostim
Omidubicel
Nalmefene
Buprenorfine
Methadone
Naltrexone

By Route of Administration:

Oral
Parenteral

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Authors get paid when people like you upvote their post.
If you enjoyed what you read here, create your account today and start earning FREE STEEM!